{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 7,
        "Importance": 8,
        "Impact": 7,
        "Duration": 6,
        "Virality": 5,
        "Source_Score": 7,
        "Specificity": 8,
        "Sector_Spread": 6,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "RT @JohnCFierce: Angling for early OK, Amgen wins 'breakthrough' title for leukemia drug blinatumomab - $AMGN - #biotech",
            "Correlation": 9,
            "Sentiment": 8,
            "Importance": 9,
            "Impact": 8,
            "Duration": 7,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 9,
            "Sector_Spread": 5,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Todays movers to research $TIF $AMGN $GOOG $ISRG",
            "Correlation": 6,
            "Sentiment": 5,
            "Importance": 5,
            "Impact": 5,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 5,
            "Specificity": 6,
            "Sector_Spread": 8,
            "Tech_Mentions": 1
        },
        {
            "News_content": "RT @AndyBiotech: $AMGN Receives FDA Breakthrough Therapy Designation For Investigational CD3xCD19 BiTE Ab Blinatumomab In Ph- r/r ALL",
            "Correlation": 10,
            "Sentiment": 9,
            "Importance": 10,
            "Impact": 9,
            "Duration": 8,
            "Virality": 6,
            "Source_Score": 9,
            "Specificity": 10,
            "Sector_Spread": 4,
            "Tech_Mentions": 3
        },
        {
            "News_content": "Bearish or Bullish on these #stocks $FDX $AMGN $AMT $EPZM #NASDAQ",
            "Correlation": 5,
            "Sentiment": 4,
            "Importance": 4,
            "Impact": 4,
            "Duration": 3,
            "Virality": 2,
            "Source_Score": 4,
            "Specificity": 5,
            "Sector_Spread": 7,
            "Tech_Mentions": 1
        }
    ]
}